中文名稱:Dutasteride | 英文名稱:Dutasteride |
CAS:164656-23-9 | 品牌: 一研 |
保存條件: Store at -20°C | 產(chǎn)品類別: 抑制劑 |
Cas : 164656-23-9 |
產(chǎn)品屬性:
產(chǎn)品名稱 | 規(guī)格 | CAS號 | 型號 |
Dutasteride | 10mM (in 1mL DMSO) 10mg 50mg | 164656-23-9 | EY-Y0165336 |
Cas No.164656-23-9
別名
化學(xué)名 (1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide
分子式 C27H30F6N2O2
分子量 528.53
溶解度 ≥ 26.4265mg/mL in DMSO
儲存條件 Store at -20°C
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping Condition Evaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
產(chǎn)品描述:
Dutasteride (Avodart) is an inhibitor of dual 5-alpha-reductase for treating benign prostatic hyperplasia (BPH).
Dutasteride has been reported to inhibit conversion of 3H-testosterone to 3H-DHT by more than 99% in LNCaP cells. Dutasteride strongly reduces growth, proliferation, and viability of LNCaP cells as well. Dutasteride increased the enzymatic activities of caspase 7 and caspase 8 dose-dependently at 48 hours, providing functional significance and confirming that the apoptotic and survival pathways are being activated by dutasteride treatment in LNCaP cells [1].
In vivo, dutasteride, which inhibits both 5αR1/5αR2, is efficacious in blocking prostate cancer development or progression in C57BL/6 TRAMP x FVB mice [2].
References:
[1] Schmidt LJ1, Murillo H, Tindall DJ. Gene expression in prostate cancer cells treated with the dual 5 alpha-reductase inhibitor dutasteride. J Androl. 2004 Nov-Dec;25(6):944-53.
[2] Opoku-Acheampong AB1, Unis D, Henningson JN, Beck AP, Lindshield BL.Preventive and therapeutic efficacy of finasteride and dutasteride in TRAMP mice. PLoS One. 2013 Oct 18;8(10):e77738. doi: 10.1371/journal.pone.0077738. eCollection 2013.
成立日期 | 2014-06-05 (11年) | 注冊資本 | 100 |
員工人數(shù) | 50-100人 | 年營業(yè)額 | ¥ 100萬以內(nèi) |
主營行業(yè) | 生化試劑,抗體,細(xì)胞培養(yǎng),分子生物學(xué),免疫安全 | 經(jīng)營模式 | 工廠,試劑 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
詢價 |
VIP1年
|
湖北鴻福達(dá)生物科技有限公司
|
2024-11-07 | |
詢價 |
VIP3年
|
普善實(shí)業(yè)(陜西)有限公司
|
2024-11-07 | |
詢價 |
VIP7年
|
河南開研生物科技有限公司
|
2024-11-07 | |
詢價 |
VIP9年
|
滄州恩科醫(yī)藥科技有限公司
|
2024-11-07 | |
詢價 |
VIP2年
|
湖北寶凌化工科技有限公司
|
2024-11-07 | |
詢價 |
VIP5年
|
上海澤葉生物科技有限公司
|
2024-11-07 | |
¥515 |
VIP3年
|
深圳摩科生化科技有限公司
|
2024-11-07 | |
詢價 |
VIP3年
|
泰安市江舟生物科技有限公司
|
2024-11-07 | |
詢價 |
VIP2年
|
武漢鼎程生科化學(xué)試劑有限公司
|
2024-11-07 | |
¥650 |
湖北瑞森蒂克生物科技有限公司
|
2024-11-07 |